You are absolutely right. We should sell stock in a Nasdaq biotech company that is receiving government grants and clinical trials are registered on a government website to buy an OTC company with no funding and no legit proof they are really doing too much of anything. Great idea!
That company is broke with over $350k in convertible debt. $ARGS has over $50 mill in cash.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.